Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
28 674 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32022R0692

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

NAŘÍZENÍ XXXXXX V PŘENESENÉ XXXXXXXXX (XX) 2022/692

xx xxx 16. února 2022,

xxxxxx xx pro xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx pokroku xxxx nařízení Evropského xxxxxxxxxx a Rady (XX) x.&xxxx;1272/2008 o klasifikaci, xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí

(Text x&xxxx;xxxxxxxx xxx XXX)

XXXXXXXX XXXXXX,

x&xxxx;xxxxxxx na Xxxxxxx x&xxxx;xxxxxxxxx Evropské unie,

s ohledem xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x.&xxxx;1272/2008 ze dne 16.&xxxx;xxxxxxxx&xxxx;2008 o klasifikaci, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx, x&xxxx;xxxxx a zrušení směrnic 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (XX) x.&xxxx;1907/2006&xxxx;(1), x&xxxx;xxxxxxx xx xx.&xxxx;37 xxxx.&xxxx;5 uvedeného xxxxxxxx,

xxxxxxxx x&xxxx;xxxxx důvodům:

(1)

Tabulka 3 x&xxxx;xxxxx 3 xxxxxxx XX nařízení (XX) x.&xxxx;1272/2008 obsahuje seznam xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxxxxx xxxxx xx xxxxxxx xxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx 2 až 5 xxxxxxx I uvedeného xxxxxxxx.

(2)

Xxxxxxxx agentuře pro xxxxxxxx xxxxx (xxxx xxx „xxxxxxxx“) xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;37 nařízení (XX) č. 1272/2008 xxxxxxxxxx xxxxxx xx zavedení xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxx x&xxxx;xx xxxxxxxxxxx xxxx zrušení xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxxx xxxxx. Xxxx, xx Xxxxx xxx xxxxxxxxxx xxxxx (XXX) xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx stran, xxxxxx x&xxxx;xxxxx xxxxxxx xxxxxxxxxxx stanoviska (2):

—

stanovisko xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 pro xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxxx v nanoformě x&xxxx;xxxxxxxxxx xxxxxxx,

—

xxxxxxxxxx xx xxx 4.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxx (ISO), [(3-fenoxy-4-fluorfenyl)kyanmethyl]-3-(2,2-dichlorvinyl)-2,2-dimethylcyklopropan-1-karboxylát,

—

stanovisko xx dne 4.&xxxx;xxxxxx&xxxx;2020 xxx β-xxxxxxxxxx (XXX); xxxxxxx směs: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx- (1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 4. května 2020 xxx xxxxxxxxxxx (XXX); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-kyan-N 1-xxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx oxid xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11. června 2020 xxx xxxxxxxxxxxxxx 2,2-dimethylpropan-1-olu; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxxxxxxxx (XXX); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11. června 2020 xxx xxxxxxxxxx,

—

xxxxxxxxxx ze dne 11.&xxxx;xxxxxx&xxxx;2020 xxx xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx,

—

xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxx (XXX); 4-(2,2-dimethylhydrazino)-4-oxobutanovou xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxx (XXX); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx,

—

xxxxxxxxxx xx xxx 11. června 2020 xxx xxxxxxxxxxx (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro xxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11. června 2020 xxx 2-xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx xxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx xxxxxxxxx vývojové xxxxxxxx {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx x&xxxx;xxxxxx xxxxxxxxxxxx a pentadraselných xxxx xx xxxxxx Xxxxxxxx xxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx),

—

xxxxxxxxxx ze xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx xxx 17. září 2020 xxx xxxxxxxxx xxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxxx (XXX); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 4,4’-xxxxx(xxxxxxxxxxxxxxxxxxxxx),

—

xxxxxxxxxx xx dne 17. září 2020 xxx xxxxxx-4-xxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx,

—

xxxxxxxxxx xx xxx 17. září 2020 pro 1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX],

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [m-XDI],

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxx xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17. září 2020 pro xxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; xxxxxxxxxxxxxxxxx-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17. září 2020 xxx 1,5-xxxxxxxxxxxxxxxxxxxx [xxxxxxxxxx < 0,1 % xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μm],

—

stanovisko ze xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [xxxxxxxxxx ≥ 0,1 % xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx než 50 μx],

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxx xxxxxx,

—

xxxxxxxxxx xx xxx 8. října 2020 pro 2,4,6-xxx-xxxx-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro pyridalyl (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx,

—

xxxxxxxxxx xx xxx 8. října 2020 pro xxxxxxx-2-xxxxx-1-xxxx, xxxxxx xxx; xxxxxx xxx xxxxxxxxxx; xxxxxxxxx xxxxx,

—

xxxxxxxxxx ze xxx 8. října 2020 xxx X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 8.&xxxx;xxxxx&xxxx;2020 pro 2-(2-xxxxxxxxxxxxx)xxxxxxx; diethylenglykolmonomethylether,

—

stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx 4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx X,

—

xxxxxxxxxx xx dne 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx,

—

xxxxxxxxxx xx dne 8.&xxxx;xxxxx&xxxx;2020 pro xxxxxxxxxxxxx (XXX); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid,

—

stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 4,4’-xxxxxxxxxxxxxxx; bisfenol X,

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 2-{N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino}ethyl-acetát; X.X. Xxxxxxxx Blue 124,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 pro xxxxxxxx xxxxxxxxxxxxxxxxxx; kyselinu xxxxxxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxx-X-(xxxxxxxxxxxxxxxxxx)-X-xxxxx-(3XX)-3-(4-xxxxxxxxxx)-β-xxxxxxxx; valifenalát,

—

stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[xxxxx-(X12-X18, rozvětvené, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx, sodné x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx,

—

xxxxxxxxxx xx xxx 10. prosince 2020 xxx 6-[xxxxx-(X10-X13, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 pro 6-[alkyl-(C12-C18, xxxxxxxxxx, nenasycené)-2,5-dioxopyrrolidin-1-yl]hexanovou kyselinu,

—

stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 1,3,5-triazin-2,4,6-triamin; melamin,

—

stanovisko xx xxx 10. prosince 2020 xxx xxxxxxx xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], xxxxxxxxxx,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx xxxxxxx, xxxxxxxx [x&xxxx;xxxxx rostliny Xxxxxxxxxxx xxxxxx, extrahovaný vodou x&xxxx;xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx],

—

xxxxxxxxxx ze dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxx xxxxxxxxx,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx bentazon (XXX), 3-isopropyl-2,1,3-benzothiadiazin-4-on-2,2-dioxid,

—

stanovisko xx xxx 10. prosince 2020 xxxxxxx xxxxxxxxxx posouzení nových xxxxxxxxx o akutní xxxxxxxxx xxxxxxxx 2-xxxxxxxxxxx-1-xxx; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) xx xxxxxx Xxxxxxxx xxxxxx.

(3)

Xxxx xxxxxxxx xxxxxxxxx informace, které xxxxxxxxxxx vědecké xxxxxxxxx xxxxxxx xx xxxxxxxxxxxx XXX ze dne 11.&xxxx;xxxxxx&xxxx;2020 pro 2-ethylhexanovou xxxxxxxx x&xxxx;xxxx xxxx; xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx posouzení xxxxxxxx toxicity {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx a jejích xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxxxxx xxxx xx xxxxxx Evropské xxxxxx, xx dne 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxx xxxxxx, xx dne 10. prosince 2020 xxx xxxx xxxxxxxxx, xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx posouzení xxxxxx informací x&xxxx;xxxxxx xxxxxxxxx xxxxxxxx 2-xxxxxxxxxxx-1-xxx; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (EGBE) na xxxxxx Evropské xxxxxx x&xxxx;xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx melamin.

(4)

Komise xxxx xxxxxxxxx xxxxxxxxx posoudila x&xxxx;xxxxxxxxxx xx xx xxxxxxxxxx x&xxxx;xxxx, aby xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxx ve xxxxxxxxxxxx XXX. Xx základě xxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxx je xxxxx xxxxxx xxxxxx, aktualizovat xxxx zrušit xxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx dotčených xxxxx.

(5)

Xxxx, xx xxxx Xxxxxx xxxxxxx xxxxxxxxxx XXX, xxxx obdrženy xxxxxxxxx informace xxxxxxxx xx akutní xxxxxxxxx xxxxxxxx silanaminu, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx hydrolýzy x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx. Xxxxxxxxxxx silanaminu, 1,1,1-trimethyl-N-(trimethylsilyl)-, xxxxxxxx hydrolýzy x&xxxx;xxxxxx xxxxxxxxxx; pyrogenního xxxxxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx 2, xxxxxxxxxx xx xxxxxxxxxx XXX xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019, xx xxxxxx xxx xxxxxxxx xx xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008, xxxxx Xxxxxx nové xxxxxxx xxxxxxxxx posoudila x&xxxx;xxxxxxxxxx, xx xx bylo xxxxx xxxxx xxxxxxxxx XXX. Xx přílohy XX xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxx xxxx xxx xxxxxxxx xxxxxxxxxxx xxxx látky xxxx STOT XX 2, xxxxxxxxxx ve xxxxxxxxxx xxxxxx RAC xx xxx 5. prosince 2019, xxxxx xxxxxx xxxxxxxx xxxxx nové informace, xxxxx xx xxxxxxxxxx xxxxx xxxxxxxxx xxxx xxxxxxxxxxx.

(6)

Xxxxxxxx (XX) č. 1272/2008 xx xxxxx mělo xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(7)

Xxxxxxxxxx xxxxxx nebo xxxxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xx xxxxxx xxx xxxxxxxxxx xxxxx, xxxxxxx xxxxxxxxxx potřebují určitou xxxx xx to, xxx přizpůsobili označování x&xxxx;xxxxxx látek x&xxxx;xxxxx xxxxx xxxx aktualizovaným xxxxxxxxxxxx x&xxxx;xxxxxxx stávající xxxxxx, xx které xx vztahují xxxxxxxxx xxxxxxxxxxx xxxxxxxxx. Xxxx xxxx xx rovněž xxxxxxxx x&xxxx;xxxx, xxx xxxxxxxxxx xxxx xxxxxxxx xxxx xxxxxxxx xxxxxxxx xxxxx k zajištění xxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxx, xxxxx vznikají x&xxxx;xxxxxxxx xxxx xxxxxxxxxxx xxxxx tohoto xxxxxxxx. Xxxxxxxxxxx xx však xxxx xxx xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxxxxxxxx harmonizované xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx xxxxxxxx přizpůsobit xxxxxxxxxx x&xxxx;xxxxxx xx xxxxxxxxxxx xxxxxxx xxxx xxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxx, xxx byla xxxxxxxxx xxxxxx úroveň xxxxxxx lidského zdraví x&xxxx;xxxxxxxxx prostředí a aby xx dodavatelům xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX TOTO XXXXXXXX:

Xxxxxx&xxxx;1

Xxxxx nařízení (XX) x.&xxxx;1272/2008

Xxxxxxx XX nařízení (XX) č. 1272/2008 xx xxxx v souladu x&xxxx;xxxxxxxx xxxxxx xxxxxxxx.

Xxxxxx&xxxx;2

Xxxxx x&xxxx;xxxxxxxx a použitelnost

Toto xxxxxxxx xxxxxxxx v platnost xxxxxxxx dnem po xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.

Xxxxxxx se xxx xxx 23.&xxxx;xxxxxxxxx 2023.

Xxxxxxxx od druhého xxxxxxxxxxx xxxxxx xxxxxx xxxxx xxx xxxxx x&xxxx;xxxxx xxxxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxx xxxxxxxxx ode xxx xxxx xxxxxx x&xxxx;xxxxxxxx.

Toto xxxxxxxx xx xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx xxxxxxxxxx xx xxxxx členských státech.

V Bruselu xxx 16.&xxxx;xxxxx 2022.

Xx Xxxxxx

xxxxxxxxxxx

Xxxxxx XXX DER XXXXX

(1)&xxxx;&xxxx;Xx. xxxx. X&xxxx;353, 31.12.2008, s. 1.

(2)  Stanoviska jsou xxxxxxxx xx xxxx xxxxxxxxxxx xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxxxxx-xx-xxx-xxxxxxxxxx-xxxxx-xxxxxxx/-/xxxxxxx/xxxx/-/xxXxxxxx/-/xxxXxxxxx/-/xxx_xxxxxxxXxxx/-/xxx_xxxxxxxXx/-/xxx_xxxxxx_xxxxxx/Xxxxxxx+Xxxxxxx/xxx_xxxxxxxxxXxxx/-/xxx_xxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxx/-/xxx_xxxxxxxxx/-/xxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxxxxXx/-/xxx_xxxxxxxxxx_xxxxxxxxx/-/. – Xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 x&xxxx;xx xxx 10. prosince 2020 xxxxxxxx xx xxxxxxxxxx xxxxxxxxx xx žádost Xxxxxxxx xxxxxx xxxx k dispozici xx xxxx xxxxxxxxxxx xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxx-xx/xxx-xx-xxx/xxxxxxxxx-xxx-xxxx-xxxxxxxxxx/xxxxxxxx-xx-xxx-xxx-xxxxxxx-xxxxx-xxxxxxxx-xxxx-x-xxxxxxxxx-xxxxxxxx-xxxxxxxx

PŘÍLOHA

Příloha XX nařízení (XX) x.&xxxx;1272/2008 xx xxxx xxxxx:

1)

x&xxxx;xxxxx 3 xx xxxxxxx 3 xxxx xxxxx:

x)

xxxxxxxx xx xxxx položky:

Indexové číslo

Chemický xxxxx

Xxxxx XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. xxxxxx, multiplikační xxxxxxx x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx a signálních xxxx

Xxxx xxxxxxxxxxxx vět x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. standardních xxx x&xxxx;xxxxxxxxxxxxx

„014-052-00-7

xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx s oxidem xxxxxxxxxx; xxxxxxxxx syntetický xxxxxxx xxxx xxxxxxxxx v nanoformě x&xxxx;xxxxxxxxxx xxxxxxx

272-697-1

68909-20-6

XXXX XX 2

X373 (xxxxx) (vdechování)

GHS08

Wng

H373 (xxxxx) (vdechování)

EUH066“

„035-005-00-7

bromid amonný

235-183-8

12124-97-9

Repr. 1X

Xxxx.

XXXX XX 3

STOT XX 1

Eye Xxxxx. 2

X360XX

X362

X336

X372 (nervový xxxxxx)

X319

XXX08

XXX07

Xxx

X360XX

X362

X336

X372 (xxxxxxx xxxxxx)

X319“

„050-032-00-4

xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx)

220-481-2

2781-10-4

Xxxx. 2

Xxxx. 1X

XXXX XX 1

X341

X360XX

X372 (xxxxxxxx xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (xxxxxxxx xxxxxx)“

„050-033-00-X

xxxxxxxxxx-xxxxxxxx

213-928-8

1067-33-0

Xxxx. 2

Xxxx. 1X

XXXX XX 1

X341

X360XX

X372 (xxxxxxxx xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (imunitní xxxxxx)“

„052-001-00-0

xxxxxx

236-813-4

13494-80-9

Xxxx. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„052-002-00-6

xxxx xxxxxxxxxxx

231-193-1

7446-07-3

Xxxx. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„056-005-00-3

xxxxxxxxx xxxxxxx-xxxxxxxx

237-222-4

13701-59-2

Xxxx. 1X

Xxxxx Tox. 4

Xxxxx Xxx. 3

H360FD

H332

H301

GHS08

GHS06

Dgr

H360FD

H332

H301

inhalační:

ATE = 1,5&xxxx;xx/x (prach nebo xxxx)

xxxxxx:

XXX&xxxx;= 100 mg/kg TH“

„601-097-00-8

propylbenzen

203-132-9

103-65-1

Flam. Xxx. 3

Xxx. Xxx. 1

XXXX XX 3

Xxxxxxx Xxxxxxx 2

H226

H304

H335

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H304

H335

H411“

„603-243-00-6

tribromderivát 2,2-dimethylpropan-1-olu; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx

253-057-0

36483-57-5; 1522-92-5

Xxxx. 1X

Xxxx. 2

X350

X341

XXX08

Xxx

X350

X341“

„604-096-00-0

xxxxxxxxxxxxxxxx (ISO); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx

200-076-7

51-03-6

XXXX XX 3

Xxx Xxxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X335

X319

X400

X410

XXX07

XXX09

Xxx

X335

X319

X410

XXX066

X&xxxx;= 1

M = 1“

„604-097-00-6

2,4,6-xxx-xxxx-xxxxxxxxxx

211-989-5

732-26-3

Xxxx. 1B

Acute Tox. 4

XXXX RE 2

Skin Xxxx. 1X

X360X

X302

X373 (játra)

H317

GHS08

GHS07

Dgr

H360D

H302

H373 (xxxxx)

X317

xxxxxx:

XXX&xxxx;= 500 mg/kg XX“

„604-098-00-1

4,4’-xxxxxxxxxxxxxxx; xxxxxxxx S

201-250-5

80-09-1

Repr. 1X

X360XX

XXX08

Xxx

X360XX“

„606-153-00-5

xxxxxxxxxx

204-337-6

119-61-9

Xxxx. 1X

X350

XXX08

Xxx

X350“

„606-154-00-0

xxxxxxxxxxx (XXX); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx

220-529-2

2797-51-5

Xxxx. 2

Xxxx. 2

Xxxxx Xxx. 4

XXXX XX 2

Xxx Xxxxx. 2

Xxxx Sens. 1&xxxx;X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H361d

H302

H373 (xxxxxx xxxx, ledviny)

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H302

H373 (xxxxxx xxxx, xxxxxxx)

X319

X317

X410

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„607-756-00-6

xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx

227-561-6

5888-33-5

Xxxx Sens. 1&xxxx;X

X317

XXX07

Xxx

X317“

„607-757-00-1

xxxxxxxxx (XXX); 4-(2,2-xxxxxxxxxxxxxxxxx)-4-xxxxxxxxxxx xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx

216-485-9

1596-84-5

Xxxx. 2

X351

XXX08

Xxx

X351“

„607-758-00-7

4,4′-xxxxx(xxxxxxxxxxxxxxxxxxxxx)

201-286-1

80-51-3

Xxxx-xxxxx. X

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X242

X400

X410

XXX02

XXX09

Xxx

X242

X410

X&xxxx;= 1

X&xxxx;= 1“

„607-759-00-2

xxxxxx-4-xxxxxxxxxxxxxxx

216-407-3

1576-35-8

Xxxx-xxxxx. X

X242

XXX02

Xxx

X242“

„607-760-00-8

2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Blue 124

239-203-6

15141-18-1

Xxxx Xxxx. 1&xxxx;X

X317

XXX07

Xxx

X317

Xxxx Xxxx. 1&xxxx;X; X317: C ≥ 0,001 %“

„607-761-00-3

perfluorheptanová xxxxxxxx; xxxxxxxxxxxxxxxxxxxxx xxxxxxxx

206-798-9

375-85-9

Xxxx. 1X

XXXX XX 1

X360X

X372 (xxxxx)

XXX08

Xxx

X360X

X372 (játra)“

„607-762-00-9

methyl-N-(isopropoxykarbonyl)-L-valyl-(3RS)-3-(4-chlorfenyl)-β-alaninát; xxxxxxxxxxx

-

283159-90-0

Xxxx. 2

Xxxxxxx Xxxxxxx 2

H351

H411

GHS08

GHS09

Wng

H351

H411“

„607-763-00-4

6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx

-

-

Xxxx. 1X

Xxx Xxxxx. 2

X360XX

X319

XXX08

XXX07

Xxx

X360XX

X319“

„607-764-00-X

6-[xxxxx-(X10-X13, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx

-

2156592-54-8

Xxxx. 1X

Xxx Xxxxx. 2

X360XX

X319

XXX08

XXX07

Xxx

X360XX

X319“

„607-765-00-5

6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx kyselina

-

-

Repr. 1X

X360XX

XXX08

Xxx

X360XX“

„613-341-00-0

xxxxxxxxxxx (XXX); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx

277-728-2

74115-24-5

Xxxxxxx Xxxxxxx 1

X410

XXX09

Xxx

X410

X&xxxx;= 1“

„613-342-00-6

theofylin; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx

200-385-7

58-55-9

Xxxx. 1B

H360D

GHS08

Dgr

H360D“

„613-343-00-1

pyridalyl (ISO); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx

-

179101-81-6

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X317

X400

X410

XXX07

XXX09

Xxx

X317

X410

X&xxxx;= 1&xxxx;000

X&xxxx;= 100“

„613-344-00-7

pyridin-2-thiol-1-oxid, xxxxx sůl; xxxxx xxx xxxxxxxxxx; xxxxxxxxx xxxxx

223-296-5;

240-062-8

3811-73-2;

15922-78-8

Xxxxx Tox. 3

Xxxxx Xxx. 3

Acute Tox. 4

XXXX RE 1

Xxxx Xxxxx. 2

Eye Xxxxx. 2

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 2

X331

X311

X302

X372 (xxxxxxx xxxxxx)

X315

X319

X317

X400

X411

XXX06

XXX08

XXX09

Xxx

X331

X311

X302

X372 (xxxxxxx systém)

H315

H319

H317

H410

EUH070

inhalační:

ATE = 0,5&xxxx;xx/x (xxxxx nebo xxxx)

xxxxxxxx:

XXX&xxxx;= 790&xxxx;xx/xx XX

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 100“

„613-345-00-2

1,3,5-triazin-2,4,6-triamin;

melamin

203-615-4

108-78-1

Carc. 2

XXXX XX 2

X351

X373 (xxxxxx xxxxx)

XXX08

Xxx

X351

X373 (močové cesty)“

„615-046-00-2

1,3-bis(1-isokyanato-1-methylethyl)benzen; [x-XXXXX]

220-474-4

2778-42-9

Xxxx. Xxxx. 1

Xxxx Xxxx. 1&xxxx;X

X334

X317

XXX08

Xxx

X334

X317“

„615-047-00-8

1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [m-XDI]

222-852-4

3634-83-1

Resp. Xxxx. 1

Skin Xxxx. 1&xxxx;X

X334

X317

XXX08

Xxx

X334

X317

Xxxx Sens. 1&xxxx;X; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“

„615-048-00-3

2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx

218-485-4

2162-73-4

Xxxx. Xxxx. 1

Xxxx Xxxx. 1

X334

X317

XXX08

Xxx

X334

X317“

„615-049-00-9

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% hmot. částic x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μm]

221-641-4

3173-72-6

STOT XX 3

Skin Xxxxx. 2

Xxx Irrit. 2

Xxxx. Xxxx. 1

Xxxx Xxxx. 1&xxxx;X

Xxxxxxx Xxxxxxx 3

X335

X315

X319

X334

X317

X412

XXX07

XXX08

Xxx

X335

X315

X319

X334

X317

X412“

„615-050-00-4

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% hmot. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším xxx 50 μx]

221-641-4

3173-72-6

Xxxxx Xxx. 2

XXXX XX 3

Xxxx Irrit. 2

Xxx Xxxxx. 2

Xxxx. Xxxx. 1

Xxxx Xxxx. 1&xxxx;X

Xxxxxxx Xxxxxxx 3

X330

X335

X315

X319

X334

X317

X412

XXX06

XXX08

Xxx

X330

X335

X315

X319

X334

X317

X412

xxxxxxxxx:

XXX&xxxx;= 0,27&xxxx;xx/x (xxxxx xxxx xxxx)“

„616-237-00-3

xxxxxxxxxxx (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx

-

239110-15-7

Xxxx. 2

X361x

XXX08

Xxx

X361x“

„616-238-00-9

xxxxxxx xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx

477-690-9

874819-71-3

Xxxx. 1X

XXXX XX 2

X360Xx

X373 (ledviny)

GHS08

Dgr

H360Fd

H373 (xxxxxxx)“

„616-239-00-4

X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; isoflucypram

-

1255734-28-1

Repr. 2

Acute Xxx. 4

Xxxx Xxxx. 1X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X332

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X361x

X332

X317

X410

xxxxxxxxx:

XXX&xxxx;= 2,2 mg/l (xxxxx xxxx xxxx)

X&xxxx;= 10

X&xxxx;= 1“

„616-240-00-X

xxxxxxx xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx a 3-(difluormethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaftalen-5-yl]pyrazol-4-karboxamid [relativní xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% anti-isomerů], xxxxxxxxxx

-

881685-58-1

Xxxx. 2

Xxxx. 1B

Skin Sens. 1X

Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1

H351

H360D

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360D

H317

H410

Repr. 1X; X360X:

X&xxxx;≥&xxxx;3&xxxx;%

X&xxxx;= 10

X&xxxx;= 10“

„650-058-00-1

Xxxxxxx, xxxxxxx [x&xxxx;xxxxx xxxxxxxx Xxxxxxxxxxx indica, xxxxxxxxxxx vodou x&xxxx;xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx]

283-644-7

84696-25-3

Xxxx. 2

Xxxx Xxxx. 1

Aquatic Xxxxxxx 1

X361x

X317

X410

XXX08

XXX07

XXX09

Xxx

X361x

X317

X410

X&xxxx;= 10“

b)

položky xxxxxxxxxxxx xxxxxxxxx xxxxxx 014-001-00-9; 023-001-00-8; 601-024-00-X; 603-014-00-0; 603-107-00-6; 604-030-00-0; 607-111-00-9; 607-230-00-6; 607-253-00-1; 607-254-00-7; 607-734-00-6; 607-735-00-1; 607-736-00-7; 608-032-00-2; 609-042-00-X; 613-012-00-1; 616-164-00-7 se xxxxxxxxx těmito xxxxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx faktory x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx a signálních xxxx

Xxxx standardních xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„014-001-00-9

xxxxxxxxxxxxx

233-042-5

10025-78-2

Xxxx. Xxx. 1

Xxxxx-xxxxx. 1

Xxxxx Tox. 3

Xxxxx Xxx. 4

Xxxx Xxxx. 1&xxxx;X

Xxx Xxx. 1

X224

X260

X331

X302

X314

X318

XXX02

XXX06

XXX05

Xxx

X224

X260

X331

X302

X314

XXX014

XXX029

XXX071

xxxxxxxxx:

XXX&xxxx;= 7,6&xxxx;xx/x (xxxx)

xxxxxx:

XXX&xxxx;= 1&xxxx;000  mg/kg TH“

„023-001-00-8

oxid xxxxxxxxx

215-239-8

1314-62-1

Xxxx. 2

Carc. 1X

Xxxx. 2

Xxxx.

Xxxxx Xxx. 3

Acute Xxx. 2

XXXX XX 3

XXXX XX 1

Aquatic Xxxxxxx 2

H341

H350

H361fd

H362

H301

H330

H335

H372 (xxxxxxx xxxxx, xxxxxxxxxx)

X411

XXX06

XXX08

XXX09

Xxx

X341

X350

X361xx

X362

X301

X330

X335

X372 (dýchací xxxxx, vdechování)

H411

inhalační:

ATE = 0,05&xxxx;xx/x (xxxxx nebo mlha)

orální:

ATE = 220&xxxx;xx/xx XX“

„601-024-00-X

xxxxx

202-704-5

98-82-8

Xxxx. Xxx. 3

Xxxx. 1B

Asp. Tox. 1

XXXX SE 3

Aquatic Xxxxxxx 2

X226

X350

X304

X335

X411

XXX02

XXX08

XXX07

XXX09

Xxx

X226

X350

X304

X335

X411“

„603-014-00-0

2-xxxxxxxxxxx-1-xx; ethylenglykol-monobutyl-ether

203-905-0

111-76-2

Acute Xxx. 3

Xxxxx Xxx. 4

Xxxx Xxxxx. 2

Eye Xxxxx. 2

X331

X302

X315

X319

XXX06

Xxx

X331

X302

X315

X319

xxxxxxxxx:

XXX&xxxx;= 3&xxxx;xx/x (xxxx)

xxxxxx:

XXX&xxxx;= 1&xxxx;200  mg/kg XX“

„603-107-00-6

2-(2-xxxxxxxxxxxxx)xxxxxxx; diethylenglykolmonomethylether

203-906-6

111-77-3

Repr. 1X

X360X

XXX08

Xxx

X360X

Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%“

„604-030-00-0

4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx X

201-245-8

80-05-7

Xxxx. 1X

XXXX XX 3

Eye Xxx. 1

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X360X

X335

X318

X317

X400

X410

XXX08

XXX07

XXX05

XXX09

Xxx

X360X

X335

X318

X317

X410

X&xxxx;= 1

X&xxxx;= 10“

„607-111-00-9

2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx;

xxxxxxxxxxxxxxxxx-xxxxxxxxxx

239-701-3

15625-89-5

Xxxx. 2

Skin Xxxxx. 2

Xxx Xxxxx. 2

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H315

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H315

H319

H317

H410

M = 1

X&xxxx;= 1

D“

„607-230-00-6

2-ethylhexanová xxxxxxxx x&xxxx;xxxx xxxx, s výjimkou xxxx, xxxxx xxxx xxxxxxx jinde x&xxxx;xxxx xxxxxxx

-

-

Xxxx. 1X

X360X

XXX08

Xxx

X360X“

„607-253-00-1

xxxxxxxxxx (XXX); [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

269-855-7

68359-37-5

Xxxx.

Xxxxx Tox. 2

Xxxxx Xxx. 2

XXXX XX 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X400

X410

XXX06

XXX08

XXX09

Xxx

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,14&xxxx;xx/x (xxxxx nebo xxxx)

xxxxxx:

XXX&xxxx;= 14&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1&xxxx;000&xxxx;000 “

„607-254-00-7

β-xxxxxxxxxx (XXX); reakční xxxx: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

-

1820573-27-0

Xxxx.

Xxxxx Tox. 2

Xxxxx Xxx. 2

XXXX XX 1

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X362

X330

X300

X370 (xxxxxxx systém)

H400

H410

GHS06

GHS08

GHS09

Dgr

H362

H330

H300

H370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,081 mg/l (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 11&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1&xxxx;000&xxxx;000 “

„607-734-00-6

xxxxxxxxxxx-2,2‘,2“,2“‘,2“&xxxx;“ -(xxxxx-1,2-xxxxxxxxxxx)xxxxxxxxxxx

404-290-3

7216-95-7

Xxxx. 1X

Xxxxx Xxx. 4

XXXX XX 2

Xxx Irrit. 2

X360X

X332

X373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X360X

X332

X373 (vdechování)

H319

Repr. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5 mg/l (xxxxx xxxx xxxx)“

„607-735-00-1

{[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx

200-652-8

67-43-6

Xxxx. 1X

Xxxxx Xxx. 4

XXXX XX 2

Xxx Xxxxx. 2

X360X

X332

X373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

X319

Xxxx. 1B; H360D: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„607-736-00-7

xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxxx)xxxxxxxxxxx]

205-391-3

140-01-2

Xxxx. 1X

Xxxxx Xxx. 4

STOT XX 2

X360X

X332

X373 (vdechování)

GHS08

GHS07

Dgr

H360D

H332

H373 (xxxxxxxxxx)

Xxxx. 1X; X360X: C ≥ 3 %

inhalační:

ATE = 1,5&xxxx;xx/x (xxxxx nebo xxxx)“

„608-032-00-2

xxxxxxxxxxx (ISO); (1E)-N-[(6-chlorpyridin-3-yl)methyl]-N’-kyan-N-methylethanimidamid; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-xxxx-X 1-xxxxxxxxxxxxxxxx

-

135410-20-7&xxxx;160430-64-8

Xxxx. 2

Xxxxx Tox. 3

Xxxxxxx Xxxxxxx 1

Aquatic Xxxxx 1

X361x

X301

X410

X400

XXX08

XXX06

XXX09

Xxx

X361x

X301

X410

xxxxxx:

XXX&xxxx;= 140&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„609-042-00-X

pendimethalin (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx

254-938-2

40487-42-1

Xxxx. 2

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 100

X&xxxx;= 10“

„613-012-00-1

bentazon (XXX); 3-xxxxxxxxx-1X-2,1,3-xxxxxxxxxxxxxxx-4(3X)-xx-2,2-xxxxxx

246-585-8

25057-89-0

Xxxx. 2

Acute Xxx. 4

Xxx Irrit. 2

Xxxx Sens. 1

X361x

X302

X319

X317

XXX08

XXX07

Xxx

X361x

X302

X319

X317

xxxxxx: XXX&xxxx;= 1&xxxx;600 &xxxx;xx/xx XX“

„616-164-00-7

xxxxxxxxxxxxx (ISO); (2X)-2-{2-[(2,5-xxxxxxxxxxxxxx)xxxxxx]xxxxx}-2-(xxxxxxxxxxxx)-X-xxxxxxxxxxxxxx; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx

149961-52-4

Xxxx. 2

Xxxx. 2

Xxxxx Xxx. 4

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H361d

H332

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H332

H410

inhalační:

ATE = 1,3&xxxx;xx/x (xxxxx nebo xxxx)

X&xxxx;= 100

X&xxxx;= 100“

x)

xxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx 615-007-00-X xx zrušuje.